Roche to acquire PathAI for USD 1.05B

FierceBiotechOdyssey voyages to Nasdaq with $304M IPO to fund autoimmune, inflammatory pipeline

LabiotechThe biggest biotech funding rounds in April 2026

Endpoints NewsNatalie Holles' next move after Third Harmonic shutdown; Mark Alles passes the torch at ADC biotech

Endpoints NewsCapricor sues Nippon Shinyaku over Duchenne drug 'pricing flaw' and launch prep

Lonza NewsLonza Says Big Pharma Might Delay Outsourcing Decisions Amid U.S. Investments - WSJ

Science Daily BiotechWhat scientists found inside coral reefs could change the future of medicine

Roche MediaRoche to acquire PathAI for USD 1.05B - Medical Buyer

Endpoints NewsOdyssey raises more than $300M as biotech goes public in IPO

Science Daily BiotechScientists find natural compounds that hit COVID-19 from every angle

FierceBiotechChutes & Ladders—Biopharma veteran takes her CEO Cue

BioPharma DiveOdyssey, on second try, snags $279M in an IPO

IQVIAIQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization - PharmiWeb.com